MSLE
Price
$5.71
Change
-$0.14 (-2.39%)
Updated
Jun 18 closing price
Capitalization
120.05M
Intraday BUY SELL Signals
SLBT
Price
$5.79
Change
-$0.59 (-9.25%)
Updated
Jun 18 closing price
Capitalization
3.25B
Intraday BUY SELL Signals
Interact to see
Advertisement

MSLE vs SLBT

MSLE vs SLBT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MSLE vs. SLBT commentary
Jun 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSLE is a Hold and SLBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2026
Stock price -- (MSLE: $5.71 vs. SLBT: $5.79)
Brand notoriety: MSLE and SLBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSLE: 73% vs. SLBT: 56%
Market capitalization -- MSLE: $120.05M vs. SLBT: $3.25B
MSLE [@Biotechnology] is valued at $120.05M. SLBT’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSLE’s FA Score shows that 1 FA rating(s) are green whileSLBT’s FA Score has 0 green FA rating(s).

  • MSLE’s FA Score: 1 green, 4 red.
  • SLBT’s FA Score: 0 green, 5 red.
According to our system of comparison, MSLE is a better buy in the long-term than SLBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSLE’s TA Score shows that 4 TA indicator(s) are bullish while SLBT’s TA Score has 4 bullish TA indicator(s).

  • MSLE’s TA Score: 4 bullish, 6 bearish.
  • SLBT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SLBT is a better buy in the short-term than MSLE.

Price Growth

MSLE (@Biotechnology) experienced а -3.22% price change this week, while SLBT (@Biotechnology) price change was -47.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLBT($3.25B) has a higher market cap than MSLE($120M). MSLE YTD gains are higher at: 1065.306 vs. SLBT (-45.092).
MSLESLBTMSLE / SLBT
Capitalization120M3.25B4%
EBITDA-30.02MN/A-
Gain YTD1065.306-45.092-2,362%
P/E Ratio3.05N/A-
Revenue0N/A-
Total Cash69.9MN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MSLE: Fundamental Ratings
MSLE
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MSLESLBT
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
40%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
22%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 25 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
MSLE
Daily Signal:
Gain/Loss:
SLBT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIMAX7.590.19
+2.57%
Cromwell Tran Sustainable Focus Investor
SFMRX38.500.67
+1.77%
American Beacon Stephens Mid-Cap Gr R6
HCMWX23.400.33
+1.43%
HCM Sector Plus A1
DFMGX33.230.35
+1.06%
DF Dent Midcap Growth Institutional
MFRLX46.380.48
+1.05%
MFS Research R1

MSLE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSLE
1D Price
Change %
MSLE100%
-2.39%
ANL - MSLE
40%
Loosely correlated
-1.56%
ACHV - MSLE
26%
Poorly correlated
-9.51%
BNTX - MSLE
25%
Poorly correlated
-1.44%
BBOT - MSLE
24%
Poorly correlated
-1.56%
DARE - MSLE
23%
Poorly correlated
+4.33%
More

SLBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLBT has been loosely correlated with NMRA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SLBT jumps, then NMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLBT
1D Price
Change %
SLBT100%
-9.25%
NMRA - SLBT
45%
Loosely correlated
-1.31%
HIND - SLBT
3%
Poorly correlated
-0.46%
DCOY - SLBT
-0%
Poorly correlated
+2.02%
MSLE - SLBT
-1%
Poorly correlated
-2.39%
KYNB - SLBT
-1%
Poorly correlated
-3.04%
More